Differential Diagnosis
DDx Strength: Weak
sacituzumab govitecan, Multiple skin lesions

Edit Findings

Exanthematous drug eruption

Exanthematous drug eruptionExanthematous drug eruption

Xerosis

XerosisXerosis

Deep vein thrombosis

Deep vein thrombosisDeep vein thrombosis

Drug-induced hepatotoxicity

Drug-induced hepatotoxicity

Drug-induced pigmentation

Drug-induced pigmentationDrug-induced pigmentation

Pruritus without rash

Pruritus without rashPruritus without rash

Dehydration

DehydrationDehydration

Drug-induced abdominal pain

Drug-induced abdominal pain

Drug-induced cough

Drug-induced cough

Drug-induced diarrhea

Drug-induced diarrhea

Drug-induced nausea or vomiting

Drug-induced nausea or vomiting

Insomnia

Insomnia

Urinary tract infection

Urinary tract infection

Chemotherapy-induced mucositis

Chemotherapy-induced mucositisChemotherapy-induced mucositis

Drug-induced alopecia

Drug-induced alopeciaDrug-induced alopecia

Drug-induced anorexia

Drug-induced anorexia

Drug-induced arthralgia

Drug-induced arthralgia

Drug-induced constipation

Drug-induced constipation

Drug-induced dizziness

Drug-induced dizziness

Drug-induced dysgeusia

Drug-induced dysgeusia

Drug-induced dyspnea

Drug-induced dyspnea

Drug-induced fatigue

Drug-induced fatigue

Drug-induced headache

Drug-induced headache

Drug-induced leukopenia

Drug-induced leukopenia

Drug-induced weight loss

Drug-induced weight loss

Hypokalemia

Hypokalemia

Hyponatremia

Hyponatremia

Peripheral neuropathy

Peripheral neuropathy

Pulmonary embolism

Pulmonary embolismPulmonary embolism

Drug-induced diabetes

Drug-induced diabetes

Drug-induced fever

Drug-induced fever

Drug-induced anemia

Drug-induced anemia